Talk:Herpes zoster: Difference between revisions

From Citizendium
Jump to navigation Jump to search
imported>Joe Quick
m (New page: {{subpages}})
 
imported>Howard C. Berkowitz
(→‎Treatment: new section)
 
Line 1: Line 1:
{{subpages}}
{{subpages}}
== Treatment ==
There is, I believe, a good deal more dispute here than these studies alone suggest. I base this not so much on RCT's, but on published clinical guidance and a substantial amount of discussion with clinicians. Having been one of the relatively rare people to have had two attacks so far, but without postherpetic neuralgia, it's a subject I track closely.
Coincidentally, I had this discussion with my primary physician recently, not for myself but in one of the end-of-the-day impromptu seminars in his office. While there's no question about the use of antivirals, he's adamantly opposed to corticosteroids; I disagree. I think there's also increasing community use of capsaicin early in the acute phase, on the argument that if it works, it's a low-risk, neurochemically reasonable approach based on Substance P depletion. It's also worth knowing if the patient cannot tolerate it, although studies are needed to determine if such individuals can tolerate it if started on a much lower concentration.
[[User:Howard C. Berkowitz|Howard C. Berkowitz]] 14:13, 30 October 2009 (UTC)

Latest revision as of 09:13, 30 October 2009

This article is developing and not approved.
Main Article
Discussion
Related Articles  [?]
Bibliography  [?]
External Links  [?]
Citable Version  [?]
 
To learn how to update the categories for this article, see here. To update categories, edit the metadata template.
 Definition Herpes virus that is responsible for chicken pox, which results in a painful blistery red rash that is confined to one side of the body. [d] [e]
Checklist and Archives
 Workgroup category Health Sciences [Categories OK]
 Subgroup categories:  Infectious Disease and Pain management
 Talk Archive none  English language variant American English

Treatment

There is, I believe, a good deal more dispute here than these studies alone suggest. I base this not so much on RCT's, but on published clinical guidance and a substantial amount of discussion with clinicians. Having been one of the relatively rare people to have had two attacks so far, but without postherpetic neuralgia, it's a subject I track closely.

Coincidentally, I had this discussion with my primary physician recently, not for myself but in one of the end-of-the-day impromptu seminars in his office. While there's no question about the use of antivirals, he's adamantly opposed to corticosteroids; I disagree. I think there's also increasing community use of capsaicin early in the acute phase, on the argument that if it works, it's a low-risk, neurochemically reasonable approach based on Substance P depletion. It's also worth knowing if the patient cannot tolerate it, although studies are needed to determine if such individuals can tolerate it if started on a much lower concentration.

Howard C. Berkowitz 14:13, 30 October 2009 (UTC)